GLP-1 Tribe

Eric Eden

The GLP-1 Community - Transforming Health Together!

Join our supportive community of people taking GLP1 medications like Ozempic and Wegovy. Sharing experiences, resources, and celebrating successes together.

This podcast is the official podcast of glp1tribe.com.

Subscribe Listen in podnod RSS feed Show website

54 episodes
Updated Jul 7, 2025

Episodes54

Newest first

May 5, 2025 · 11 min
New Research on 2 Million People shows the 28 Benefits and 16 Risks of Ozempic and Wegovy
In this episode we look at the extensive research on the benefits and risks of GLP-1s based on a study of almost 2 million patients. A groundbreaking study published in the respected science journal Nature. The research explored how GLP-1 receptor agonists (like Ozempic and Wegovy) impact 175 health conditions. Total Participants: 1,955,135 individuals Follow-up Period: Median of 3.68 years (range: 2.05-5.37 years) Total Study Duration: 7,239,854 person-years Key Objective: Systematically examine associations between GLP-1 receptor agonist use and 175 health outcomes Picture this: a team of dedicated researchers tracking nearly two million people over several years. To put this into perspective, most medical studies might include a few thousand participants. This study represents the gold standard: large-scale, long-term and rigorously documented. The results show that GLP-1 medications can help with many health problems, from heart disease to mental health. However, the study also points out some risks, especially with gastrointestinal issues and kidney health. Though there are still risks to consider, this research shows how far we’ve come in understanding and improving health. We still have challenges to face, but it highlights how much we can achieve when we truly understand our bodies. Read our companion blog post on this episode
May 1, 2025 · 20 min
Getting Zepbound Insurance Coverage or Zepbound Discounts for an Affordable Weight Loss Journey
This episode provides a comprehensive guide on navigating the complexities of obtaining insurance coverage for the medication Zepbound. Zepbound is a GLP-1 weight loss medication made by Eli Lilly We outline the steps involved with both private insurance and Medicaid, explaining key terms like prior authorization (PA), deductibles, and copays. The texts emphasize the importance of documenting weight-related comorbidities and the recent FDA approval of Zepbound for obstructive sleep apnea (OSA) as factors that can increase the likelihood of coverage, particularly with Medicare. Furthermore, they detail the appeal process for denials and offer cost-saving strategies, including manufacturer savings cards and patient assistance programs. We have a companion blog post with all the details for this episode on getting Zepbound insurance coverage here on the GLP-1 Tribe web site. https://www.glp-1tribe.com/how-to-get-zepbound-covered-by-insurance-and-save-money/
Apr 29, 2025 · 22 min
GLP-1 Weight Loss Medication Dosage Guide for Wegovy and Zepbound
This podcast offers a comprehensive guide to using GLP-1 medications like Wegovy and Zepbound for weight management, highlighting that these injectable drugs are adjuncts to diet and exercise, not standalone solutions. In this podcast we detail the gradual dose escalation schedules ("start low, go slow") designed to improve tolerability and minimize common gastrointestinal side effects as the body adjusts to the medication. They emphasize that the initial doses are primarily for acclimatization and that reaching the full therapeutic effect requires patience over several months. This episode reviews alternative strategies some healthcare providers use with patients. Crucially, this episode underscores the importance of long-term use for sustained weight management, as stopping the medication often leads to weight regain, and stress the need for a strong partnership with a healthcare provider to tailor dosing based on individual response, tolerability, and overall health. Our companion detailed blog post for this episode is here - https://www.glp-1tribe.com/the-patients-guide-to-glp-1-weight-loss-medications-understanding-dosages-side-effects-and-strategies-for-wegovy-and-zepbound/
Apr 23, 2025 · 17 min
Can You Lose More Weight Switching from Wegovy or Ozempic to Zepbound?
We tackle the question in this episode if switching GLP-1 medicines can help patients beat the weight loss stall and lose more weight. This episode discusses reasons for switching medications, such as weight loss plateaus, and details the typical process under medical supervision. Furthermore, it emphasizes the crucial role of lifestyle modifications for successful and sustained weight management and addresses long-term maintenance, potential side effects, cost considerations, and insurance coverage for these medications. We have a detailed companion blog post on this topic - https://www.glp-1tribe.com/switching-your-weight-loss-injection-a-guide-to-moving-from-wegovy-or-ozempic-to-zepbound/ This is the official podcast of GLP-1 Tribe. Find all the best resources about GLP-1 on the GLP-1 Tribe web site. https://glp1tribe.com/
Apr 23, 2025 · 16 min
Eating Well on Your GLP-1 Journey: A Guide for Maximizing Results and Minimizing Side Effects on Wegovy, Zepbound or Ozempic
In this episode we discuss the ideal GLP-1 diet and how to eat well while on Wegovy, Ozempic, or Zepbound and get the best weight loss results. Check out these free GLP-1 resources for eating well GLP-1 Optimized Recipe Creator - Create GLP1 optimized recipes in real time GLP-1 Weekly Meal Planner - Create an entire week o GLP-1 meals - and the shopping list for all those meals in just seconds! The GLP-1 Recipe Library is hundreds of optimized recipes you can browse for inspiration on your journey
Apr 21, 2025 · 32 min
Your Guide to Building Muscle While Losing Weight on GLP-1 Medications like Ozempic, Wegovy, and Zepbound
Why Keeping Muscle Matters More Than You Think! GLP-1 Weight Loss: A Strength Training Guide to Preserve Muscle This podcast offers guidance on integrating strength training while on a weight loss journey that utilizes GLP-1 medications like Ozempic, Zepbound and Wegovy. We highlight the tendency for individuals on these medications to lose muscle mass alongside fat and emphasize the critical role of strength training and adequate protein intake in preserving and building muscle. The podcast provides practical advice for beginners on how to start strength training, including exercise examples, recommended routines, and strategies for managing potential GLP-1 side effects to maintain an active lifestyle. Ultimately, we advocate for a comprehensive approach that combines medication with exercise and proper nutrition to achieve healthy and sustainable weight loss while improving body composition and overall well-being. We have a free and comprehensive blog post article on this topic as well. This is the official podcast of GLP-1 Tribe. Find all the best resources about GLP-1 on the GLP-1 Tribe web site. https://glp1tribe.com/
Apr 12, 2025 · 17 min
Beyond Weight Loss: The Massive Benefits of GLP-1 Medications - Non Scale Victories on Wegovy, Zepbound, and Ozempic
GLP-1 Medications: 10 Major Health Benefits Beyond Weight Loss GLP-1 receptor agonist medications, such as Wegovy, Ozempic, Mounjaro, and Zepbound, initially developed for diabetes, offer substantial health benefits extending beyond weight loss. These "non-scale victories" include improvements in cardiovascular health, such as blood pressure and cholesterol, reduced inflammation, and better metabolic markers like blood sugar control. Patients also experience enhanced physical well-being, with increased mobility, less joint pain, and improved sleep, and report psychological benefits like increased energy and better mood, leading to a higher overall quality of life. While these medications share core mechanisms, newer dual-agonists like tirzepatide (Mounjaro/Zepbound) may provide more pronounced effects on weight and related health parameters, highlighting a holistic approach to improved health. Read our while blog post on this topic This is the official podcast of GLP1 Tribe
Apr 10, 2025 · 21 min
Having the Conversation about Weight Loss and Overcoming Stigmas with Friends, Family, and Coworkers while on Wegovy - Zepbound - Ozempic
Your Body, Your Journey, Your Conversation: Navigating Social Life While Taking GLP-1 Weight Loss Medications This episode explores the multifaceted experience of individuals using GLP-1 medications for weight loss, addressing the significant physical and internal changes that occur. We highlight the common challenge of navigating social conversations about this visible transformation, focusing on the societal stigma surrounding weight loss drugs and the misconception of them being an "easy way out." Or even worse "why dn't you jus diet and exercise" The episode emphasizes the importance of personal autonomy in deciding what and when to share, offering strategies for crafting empowering narratives that focus on overall health rather than just weight. Furthermore, it underscores the necessity of setting healthy boundaries to protect one's emotional well-being and shares personal experiences to provide validation and practical insights for people who need to have these tough conversations. This is the official podcast of GLP-1 Tribe. Find all the best resources about GLP-1 on the GLP-1 Tribe web site. https://glp1tribe.com/
Apr 10, 2025 · 21 min
Overcoming Weight Loss Stalls and Plateaus on Wegovy or Zepbound
Wegovy & Zepbound: Overcoming Weight Loss Plateaus The podcast explain that weight loss plateaus are a common occurrence for individuals using GLP-1 medications like Wegovy and Zepbound. But there is a way to continue to get great progress and results. These medications, which mimic gut hormones to suppress appetite and slow digestion, initially lead to significant weight loss, but the body adapts over time, causing progress to stall. The podcast discuss physiological reasons for plateaus, such as metabolic adaptation and hormonal shifts, as well as behavioral and lifestyle factors, including dietary changes, reduced physical activity, stress, and sleep. To overcome these plateaus, the podcast suggests practical strategies to overcome the stall. This is the official podcast of GLP-1 Tribe. Find all the best resources about GLP-1 on the GLP-1 Tribe web site. https://glp1tribe.com/
Apr 8, 2025 · 16 min
Top 10 Ways to Maximize Weight Loss on Wegovy and Zepbound
This episode offers guidance on maximizing weight loss while using the medications Wegovy and Zepbound. It highlights that while these GLP-1 receptor agonists are effective for weight reduction, individual results vary. The article presents ten evidence-based strategies focusing on diet, hydration, exercise (both cardio and strength training), sleep, stress management, and consistent communication with healthcare providers. These recommendations aim to help individuals exceed average weight loss outcomes and promote long-term success. Furthermore, the text emphasizes the importance of integrating these medications with comprehensive lifestyle changes for optimal and sustained results.
Apr 7, 2025 · 20 min
The Risks of Compounded Semaglutide and Tirzepatide: Navigating the Shift from Shortage Relief to Safety Concerns
Compounded semaglutide and tirzepatide provided a vital stopgap during shortages, but their role has come under scrutiny as supply stabilizes. While affordability remains a pressing issue—particularly for those without insurance coverage—the risks of inconsistent quality, contamination, and adverse effects cannot be ignored. With pharmaceutical giants like Eli Lilly pushing for tighter restrictions and the FDA signaling a return to regulated channels, consumers face a pivotal choice. Injecting these medications demands confidence in their safety, and for now, the surest path lies with FDA-approved products. For those still drawn to compounded options, rigorous due diligence and medical oversight are non-negotiable steps to mitigate the gamble. This is the official podcast of GLP-1 Tribe. Find all the best resources about GLP-1 on the GLP-1 Tribe web site. https://glp1tribe.com/
Apr 5, 2025 · 15 min
Medicare Won't Cover GLP-1 Drugs for Weight Loss. Accessing GLP-1 Medications on Medicaid and Medicare
These sources offer a comprehensive overview of accessing GLP-1 medications for individuals in the United States who rely on Medicaid and Medicare. The Centers for Medicare & Medicaid Services said this week it did not move forward with a proposal put forth by the Biden administration for Medicare coverage of weight-loss drugs such as Novo Nordisk's Wegovy. They highlight the complexities of coverage, which often differs based on the medication's approved use (diabetes vs. weight loss) and the specific state or Medicare plan. The texts explore alternative pathways for obtaining these costly drugs, such as patient assistance programs and state initiatives. Furthermore, they discuss the crucial role of advocacy groups and potential future policy changes that could broaden access. Finally, the sources provide practical tips for beneficiaries navigating insurance requirements, prior authorizations, and appeals processes. This is the official podcast of GLP-1 Tribe. Find all the best resources about GLP-1 on the GLP-1 Tribe web site. https://glp1tribe.com/
Apr 5, 2025 · 24 min
Strategies for Getting Insurance Coverage for GLP-1 Medications - Best Practices for US Consumers
GLP-1 Insurance Coverage Strategies: This podcast synthesizes information from 100+ sources on navigating private insurance coverage for Glucagon-like peptide-1 (GLP-1) receptor agonists in the US. These medications are increasingly important for managing type 2 diabetes and chronic weight management but often face coverage challenges due to their high cost and varying insurance policies. The podcast outlines common reasons for denial, proactive strategies for approval, and key aspects of the prior authorization and appeals processes. Main Themes: The Growing Importance and Accessibility Challenges of GLP-1 Medications Understanding Common Reasons for Insurance Denial Proactive Strategies are Essential for Securing Coverage Navigating Prior Authorization is a Key Hurdle Comprehensive Documentation and Medical History are Crucialz The Insurance Appeal Process Offers Recourse Physicians Play a Vital Advocacy Role External Support and Resources are Available Different Insurance Plan Types (HMO vs. PPO) Impact Coverage Obtaining insurance coverage for GLP-1 medications requires a proactive and informed approach. By understanding the reasons for potential denial, implementing strategic best practices, and leveraging available resources, consumers can significantly improve their chances of accessing these important treatments. Collaboration with healthcare providers, meticulous documentation, and persistence through the prior authorization and appeal processes are crucial for navigating the complex insurance landscape. This is the official podcast of GLP-1 Tribe. Find all the best resources about GLP-1 on the GLP-1 Tribe web site. https://glp1tribe.com/
Apr 5, 2025 · 10 min
The Rise of GLP-1 Medications in the United States: Adoption, Usage, and Economic Impact
GLP-1 receptor agonists have rapidly transformed the landscape of diabetes and weight management treatment in the United States and globally. Initially approved for type 2 diabetes, these medications—including brands like Ozempic, Wegovy, Mounjaro, and Zepbound—have gained widespread attention for their effectiveness in both glycemic control and significant weight loss. This article examines the current state of GLP-1 adoption, growth trends, and the complex economic factors surrounding their use. Adoption Rates in the United States As of mid-2024, approximately 10-12 million Americans were estimated to be taking GLP-1 medications for diabetes or weight management. This represents a substantial increase from just 3-4 million users in 2020. The adoption has been particularly pronounced since the FDA approval of semaglutide (Wegovy) for weight management in June 2021 and tirzepatide (Zepbound) in late 2023. Morgan Stanley analysts projected that by the end of 2024, the number of Americans using these medications could reach 15 million, representing about 4.5% of the U.S. adult population. Global Usage Patterns Globally, GLP-1 medication usage reached approximately 40 million patients by mid-2024, with the highest adoption rates in North America and Europe. The Asia-Pacific region has shown increasing adoption. Growth Trajectory Over Five Years The growth rate of GLP-1 medications in the United States has been nothing short of extraordinary: 2019-2020: ~20% year-over-year growth (primarily diabetes indications) 2020-2021: ~45% growth (increasing off-label use for weight management) 2021-2022: ~85% growth (following Wegovy approval for weight management) 2022-2023: ~110% growth (expanding insurance coverage and awareness) 2023-2024: ~70% growth (supply constraints moderating growth despite demand) This represents a compound annual growth rate (CAGR) of approximately 60% over the five-year period, making GLP-1 medications one of the fastest-growing pharmaceutical categories in U.S. history. The Economics of GLP-1 Medications Pricing Structure The retail price for monthly prescriptions of GLP-1 medications in the United States typically ranges from $900 to $1,350, depending on the specific medication and dosage: Semaglutide (Ozempic/Wegovy): $900-$1,300 per month Tirzepatide (Mounjaro/Zepbound): $1,000-$1,350 per month Liraglutide (Victoza/Saxenda): $850-$1,200 per month These prices have remained relatively stable despite growing demand, with manufacturers offering savings programs to qualified patients while maintaining high list prices for negotiation with insurance companies. Future Outlook Analysts project that by 2030, if current trends continue and supply constraints are resolved, the U.S. could see 25-30 million users of GLP-1 medications, representing a market exceeding $100 billion annually. Their rapid adoption represents a paradigm shift in how obesity is medically addressed in the United States. However, the economic considerations—including high costs, insurance coverage limitations, and healthcare system impacts—remain significant challenges. As usage continues to grow, finding sustainable economic models for these effective but expensive medications will be crucial for ensuring equitable access while managing healthcare costs. This is the official podcast of GLP-1 Tribe. Find all the best resources about GLP-1 on the GLP-1 Tribe web site. https://glp1tribe.com/
Apr 5, 2025 · 20 min
Why are GLP-1 Medications 10X More Expensive in the USA? Who Pays for the Most Prescribed Medications in America?
This report synthesizes information from 100+ sources regarding the significant price disparities for Glucagon-Like Peptide-1 (GLP-1) receptor agonists (e.g., Wegovy, Ozempic, Zepbound, Mounjaro) between the United States and other developed countries like Canada, the United Kingdom, and nations within the European Union (primarily Germany and France). The analysis reveals that the higher costs in the US are a result of a complex interplay of factors, including pharmaceutical company pricing strategies, the unique structure of the US healthcare system (particularly the role of insurance companies and Pharmacy Benefit Managers (PBMs)), the absence of direct government negotiation on drug prices, robust patent laws and market exclusivity, and the impact of direct-to-consumer advertising. PBM practices, specifically rebate negotiations and formulary management, are highlighted as significant contributors to maintaining high list prices and creating a disconnect between negotiated discounts and patient out-of-pocket expenses. Key Findings and Themes: Significant Price Disparities Pharmaceutical Company Pricing Strategies Fragmented US Healthcare System and the Role of PBMs Robust Patent Laws and Market Exclusivity Implications: The high cost of GLP-1 medications in the US has significant implications, including: Restricted patient access due to affordability issues. Higher overall healthcare spending. Potential negative impacts on public health outcomes. Disproportionate financial burden on uninsured or underinsured individuals and those in high-deductible plans. Policy Considerations (as suggested by the sources): Exploring mechanisms for government negotiation of drug prices. Re-evaluating the balance between patent protection and drug affordability. Considering regulations around direct-to-consumer advertising. Increasing transparency and reforming the practices of Pharmacy Benefit Managers (PBMs), such as delinking rebates from list prices and banning spread pricing. The elevated cost of GLP-1 medications in the United States is a multifaceted problem stemming from a unique combination of market dynamics, regulatory frameworks, and the behaviors of key players within the pharmaceutical supply chain. Addressing this issue will require comprehensive policy interventions that tackle pricing strategies, the role of intermediaries, and the broader healthcare system to ensure equitable access to these important therapies. This is the official podcast of GLP-1 Tribe. Find all the best resources about GLP-1 on the GLP-1 Tribe web site. https://glp1tribe.com/
Apr 4, 2025 · 23 min
Strategies and Tips for Battling Nausea on Wegovy and Zepbound
GLP-1 Medication Nausea: Management Strategies and Tips The episode extensively explores the common side effect of nausea experienced by 50% individuals using GLP-1 medications for type 2 diabetes and weight loss. We explain why nausea occurs, detailing the medication's impact on gastric emptying and brain signaling. The sources offer a range of management strategies, including dietary adjustments like eating smaller, bland meals and avoiding trigger foods, as well as lifestyle modifications such as prioritizing hydration and rest. Furthermore, they discuss over-the-counter and prescription remedies, such as ginger, peppermint, and antiemetic drugs, while emphasizing the importance of consulting healthcare professionals for persistent or severe symptoms. This is the official podcast of GLP-1 Tribe. Find all the best resources about GLP-1 on the GLP-1 web site. https://glp1tribe.com/
Apr 2, 2025 · 19 min
Do you need to get in 10,000 steps a day when taking Wegovy, Ozempic, or Zepbound?
In this episode we discuss daily, weekly and monthly exercise impact for patients on GLP-1 medicines like Wegovy, Ozempic, and Zepbound, explaining how exercise aids in weight loss and blood sugar control. We emphasize that physical activity is crucial for maximizing the benefits of these medications, including enhanced weight loss, muscle preservation, and improved cardiovascular health. While 10,000 daily steps is a popular goal, the sources suggest focusing on general time-based exercise recommendations from health organizations, incorporating aerobic, strength, flexibility, and balance exercises. Furthermore, they advise individualizing exercise plans, considering potential medication side effects, and consulting healthcare providers for safe and effective integration of activity with GLP-1 therapy. A new free calculator from GLP1 Tribe to track the impact of how many steps you take every day on weight loss. https://www.glp1tribe.com/walking-calculator
Apr 1, 2025 · 10 min
Is Drinking More Water the Key to Losing More Weight on Wegovy, Ozempic or Zepbound?
In this episode we explore if drinking more water is the secret to losing more weight on a GLP-1 like Ozempic, Wegovy or Zepbound. Drinking more water helps you lose more weight because: Reduces side effects from GLP-1 medications (especially constipation and nausea) Helps maintain energy levels and cognitive function Supports kidney function for processing medications Promote healthy digestion Supports your metabolism and weight management I think the general estimate we were told as kids to drink 8 cups of water a day is probably not enough water for most people on a GLP-1. How much is enough water every day? It depends on a number of variables including your age, activity level, weight, climate etc. The math gets pretty complex so we created a free Drink More Water calculator that calculates a personal estimate for how much water people on GLP-1 journey should drink daily to lose more weight. https://glp1tribe.com/water-calculator One good rule of thumb is half your body weight in ounces of water each day. On top of that, many healthcare professionals have suggested people on GLP-1 should drink 10% more water than the normal person. But the reason for the calculator is when you factor in all the variables we should probably drink a lot more water than we think. - Consider using one of the cool bluetooth water bottles that connects to an app and tracks your daily water consumption. - One thing I have found helpful is drinking small sips of water all day instead of a lot at once. - Watermelon is great because it's 92% water! The good news is testing if drinking more water improves results is free and easy thing for everyone to try. I hope this is helpful for others.
Mar 31, 2025 · 17 min
How Long Should People Take Ozempic, Wegovy, or Zepbound? What is Maintenance Mode? Long Term Usage Pros and Cons
The duration of GLP-1 medication use is often long-term for both type 2 diabetes and weight management, with many patients continuing on these medications in a "maintenance mode" after achieving initial treatment goals. This maintenance phase is crucial for sustaining weight loss, maintaining glycemic control, and potentially realizing the cardioprotective and renoprotective benefits associated with GLP-1 receptor agonists. While long-term GLP-1 therapy offers significant advantages, it is essential to consider the potential risks, side effects, and the often substantial cost of these medications. The decision regarding the appropriate duration of treatment is highly individualized and should be made through a collaborative discussion between the patient and their healthcare provider, taking into account factors such as treatment response, individual goals, presence of comorbidities, tolerability, lifestyle, and socioeconomic considerations. Continuous monitoring is vital for patients in maintenance mode to ensure ongoing effectiveness and to detect any potential long-term adverse effects. Finally, while GLP-1 medications are a powerful tool, a holistic approach to managing weight and blood sugar should always include lifestyle modifications, and patients should be aware of alternative strategies that can support their long-term health and well-being. When used appropriately and for the necessary duration, GLP-1 receptor agonists hold significant promise in improving the health and quality of life for individuals with type 2 diabetes and obesity.
Mar 30, 2025 · 26 min
Guide to Avoiding Hair Loss on Wegovy, Ozempic and GLP-1 Medications
This podcast explain the connection between GLP-1 medications, such as Ozempic and Wegovy, and hair loss experienced by some users. The research and science clarifies that hair loss is often a temporary condition, primarily resulting from the physiological stress of rapid weight loss and potential nutrient deficiencies rather than a direct effect of the drugs. The sources offer expert guidance and practical strategies for minimizing hair shedding, including focusing on a nutrient-dense diet, considering supplements with medical advice, adopting gentle hair care practices, and managing stress. They also discuss the typical timeline for hair regrowth and when seeking professional medical help is recommended.